-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Cullinan Therapeutics, Inc. annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2021 to Q1 2023.
- Cullinan Therapeutics, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $0.000.
- Cullinan Therapeutics, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $5.4M.
- Cullinan Therapeutics, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was $0.000.
Deferred Income Tax Expense (Benefit), Quarterly (USD)